Multiple Sclerosis: key references and evidence

References

Allison RS, Millar JH. Prevalence and familial incidence of disseminated sclerosis (a report to the Northern Ireland Hospitals Board on the results of a three year study). Prevalence of disseminated sclerosis in Northern Ireland. Ulster Med J 1954;23 (supp 2):5-27.

Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurology 2010;9(6):599-612.

Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17.

Donnan PT, Parratt JD, Wilson SV, Forbes RB, O'Riordan JI, Swingler RJ. Multiple sclerosis in Tayside, Scotland: detection of clusters using a spatial scan statistic. Multiple Sclerosis 2005;11:403-8.

Forbes RB, Swingler RJ. Estimating the prevalence of Multiple Sclerosis in the United Kingdom using capture-recapture methodology. American Journal of Epidemiology 1999; 149:1016-24.

Forbes RB, Wilson SV, Swingler RJ. The prevalence of MS in Tayside, Scotland. Do latitudinal gradients really exist? Journal of Neurology 1999; 246: 1033-40.

Grant RM. Carver AD. Sloan RL. Multiple sclerosis in Fife. Scottish Medical Journal 1998; 43:44-7.

Kurtzke JF. The epidemiology of multiple sclerosis. In Raine CS, McFarland HF, Tourtellotte WW eds. Multiple sclerosis.Clinical and pathogenetic basis , first edition. London: Chapman and Hall, 1997, 105-/107.

Lucas RM, Hughes AM, Lay M-LJ, et al. Epstein-Barr virus and multiple sclerosis. J Neurol Neurosurg Psychiatr 2011;82:1142–8. doi:10.1136/jnnp-2011-300174

McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis:guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121-7.

Multiple Sclerosis Society/ MS Research Trust. Standards of Healthcare for people with MS. Multiple Sclerosis Society, London Updated 1999 and 2002.

Munger KL, Ascherio A. Prevention and treatment of MS: studying the effects of vitamin D. Multiple Sclerosis Journal 2011;17:1405–11. doi:10.1177/1352458511425366

Murray S. Bashir K. Penrice G. Womersley SJ. Epidemiology of multiple sclerosis in Glasgow. Scottish Medical Journal 2004; 49:100-4.  

National Institute for Clinical Excellence. Multiple Sclerosis. Management of multiple sclerosis in primary and secondary care(152Kb) Clinical Guideline 8. National Institute for Clinical Excellence, London, 2003.

Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31

Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005;58 (6): 840 - 6. doi:10.1002/ana.20703

Rothwell PM Charlton D. High incidence and prevalence of MS in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998; 64: 730 -735.

Scottish Needs Assessment Programme. Multiple Sclerosis. Scottish Needs Assessment Programme (SNAP) report. Department of Public Health, University of Glasgow. October 2000.

UK Department of Health. The national service framework for long-term conditions London, 2005.

Willer CJ, Dyment DA, Sadovnick AD et al. Timing of birth and risk of multiple sclerosis: population based study.  BMJ 2005: 330:120-23.

Effectiveness evidence

ScotPHO's purpose is to describe the pattern of health across the Scottish population. As a supplementary service to users, we include the following links to external sources of quality-assured evidence on effectiveness of interventions which may include relevant material for this topic. These links are provided as an aid to users. They are by no means exhaustive nor should they be necessarily viewed as authoritative.

NHS Health Scotland: Scottish briefings on NICE public health guidance

Centre for Reviews and Dissemination

Cochrane Library: Browse by topic

EPPI-Centre: Evidence library

National Institute for Health and Care Excellence (NICE) Evidence services: Evidence search

National Institute for Health and Care Excellence (NICE) Guidance: Find guidance

Scottish Intercollegiate Guidelines Network (SIGN)

Please note: ScotPHO is not responsible for the content or reliability of linked websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. ScotPHO can take no responsibility for information contained on websites maintained by other organisations or for actions taken as a result of information contained on websites maintained by other organisations.

To report a broken link on the ScotPHO website, please email details to the This e-mail address is being protected from spambots. You need JavaScript enabled to view it of the web page containing the broken link together with the web address you were unable to access.